Diamond Chemical Co. v. Atofina Chemicals, Inc.

268 F. Supp. 2d 1, 2003 U.S. Dist. LEXIS 10549, 2003 WL 21464563
CourtDistrict Court, District of Columbia
DecidedJune 5, 2003
DocketCIV.A.02-1018 CKK
StatusPublished
Cited by77 cases

This text of 268 F. Supp. 2d 1 (Diamond Chemical Co. v. Atofina Chemicals, Inc.) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diamond Chemical Co. v. Atofina Chemicals, Inc., 268 F. Supp. 2d 1, 2003 U.S. Dist. LEXIS 10549, 2003 WL 21464563 (D.D.C. 2003).

Opinion

MEMORANDUM OPINION

KOLLAR-KOTELLY, District Judge.

Pending before the Court is Defendant Total Fina Elf S.A.’s (“TFE” or “Defendant”) Motion to Dismiss brought pursuant to Federal Rules of CM Procedure 12(b)(2) and 12(b)(6), and Diamond Chemical Company’s (“Plaintiff’) Motion for Leave to Take Jurisdictional Discovery. Both motions are opposed. Upon consideration of TFE’s Motion and supporting memorandum, Plaintiffs Motion and supporting memorandum, both parties’ Opposition and Reply briefs, the submitted evidence, and the relevant law, the Court shall grant Plaintiffs request for jurisdictional discovery and deny without prejudice Defendant’s Motion to Dismiss.

I: BACKGROUND

Plaintiff filed its complaint in this case on May 23, 2002, on behalf of itself and all others similarly situated, claiming damages from Defendants’ alleged antitrust conspiracy involving sodium monochlor-oacetate and monochloroacetic acid (collectively referred to as “MCAA”). Plaintiffs Complaint (“Compl.”) ¶ 1; see also Memorandum in Support of TFE’s Motion to Dismiss (“TFE Mem.”) at l. 1 Plaintiff claims that the alleged conspiracy ran “from at least September 1, 1995 through August 31,1999.” Compl. ¶ 2.

Named Defendants pertinent to the pending motion are as follows. Plaintiff alleges that Atofina Chemicals, Inc. (“Ato-fina N.A.”) “is a corporation organized under the laws of Pennsylvania, with its office and principal place of business located [in] Philadelphia, Pennsylvania.” Compl. ¶ 10. During the period of the alleged conspiracy, Plaintiff states that “Atofina’s predecessor, Atochem North America, Inc., which changed its name to Elf Ato-chem North America, Inc. in 1992, was engaged in the manufacture, distribution and sale of MCAA in the United States and elsewhere.” Id. According to Plaintiff, Atofina N.A. was “dominated and controlled” and indirectly owned until 2000 by Defendant Elf Atochem S.A. (“Atochem”), a French corporation with its principal place of business in France. Id. ¶ 11. Defendant Atochem was a subsidiary of Elf Aequitaine S.A. until TotalFina S.A. purchased the shares of Elf Aquitaine S.A. in October of 1999. Def. Reply at 12 n. 9.

Defendant Atofina S.A., according to Plaintiff, is a French corporation with its *5 principal place of business in France, which owns a minority of the shares of Atofina Delaware, Inc. which in turn owns the majority of shares of defendant Atofina N.A. Compl. ¶ 12. Plaintiff claims that Atofina S.A. “succeeded to the assets and obligations of Atochem, including indirect ownership of Atofina N.A., and since then has dominated and controlled the business of Atofina N.A.” Id. Plaintiff also asserts that Atofina S.A. was engaged in the manufacture, distribution and sale of MCAA in the United States and elsewhere during the period of the alleged antitrust conspiracy. Id.

Defendant TFE, according to Plaintiff, is a French Corporation with its principal place of business in France. Id. ¶ 13. Total Fina Elf S.A. is the name taken by TotalFina S.A. after its acquisition of Elf Aquitaine S.A in October of 1999. PL Reply at 8 n. 3, 12 n. 8. Plaintiff claims that TFE was engaged in the manufacture and sale of MCAA in the United States and elsewhere during the alleged conspiracy period. Compl. ¶ 13 Plaintiff contends that TFE has been the “ultimate parent ... and has dominated and controlled the business of Atochem, Atofina S.A., [and] Atofina N.A.” Id. After the stock purchase, all of TotalFina and Elf Acquitaine’s chemical companies were reorganized under the name “Atofina.” Plaintiffs Opposition to Defendant’s Motion to Dismiss (“PI. Opp’n”) at 10 (citing Mary Strimel Aff. at Ex. 6).

One named Defendant, Atochem, pled guilty to an antitrust violation with respect to MCAA. Compl. ¶ 1; TFE Mem. at 1. Defendants Atochem and Atofina S.A. filed Answers in this action on August 18, 2002, while Defendant Atofina N.A. filed its Answer on June 20, 2002. TFE filed this Motion to Dismiss on August 23, 2002, claiming this Court lacks personal jurisdiction and that Plaintiff has failed to state a claim upon which relief may be granted.

II: DISCUSSION

A. Personal Jurisdiction over Defendant TFE

When a defendant timely objects to a court’s personal jurisdiction, the “general rule is that a plaintiff must make a prima facie showing of the pertinent jurisdictional facts.” First Chicago Int’l v. United Exch. Co., 836 F.2d 1375, 1378 (D.C.Cir.1988); see also McNutt v. General Motors Acceptance Corp., 298 U.S. 178, 182, 56 S.Ct. 780, 80 L.Ed. 1135 (1936) (holding that plaintiff bears the burden of proving essential jurisdictional facts). Requiring more than “bare allegation[s],” this Circuit has held that “a plaintiff ‘must allege specific acts connecting [the] defendant with the forum.’ ” First Chicago, 836 F.2d at 1378 (quoting Greenspun v. Del E. Webb Corp., 634 F.2d 1204, 1208 n. 5 (9th Cir.1980)).

Plaintiff in its Opposition to TFE’s motion to dismiss, alleges that this Court has general jurisdiction over TFE pursuant to D.C.Code § 13-334(a), specific jurisdiction over TFE pursuant to the District of Columbia’s long-arm statute, D.C.Code § 13-423, and jurisdiction under the special venue provision of the Clayton Act, 15 U.S.C. § 22. PI. Opp’n at 7, 8, 14. The Court shall first examine general jurisdiction under District of Columbia law, then the Clayton Act’s venue provision, and finally examine Defendant’s contacts under the D.C. long arm statute.

1. General Jurisdiction under District of Columbia Law

Under the laws of the District of Columbia, courts may “exercise ‘general jurisdiction’ over a foreign corporation as to claims not arising from the corporation’s conduct in the District, if the corporation *6 is ‘doing business’ in the District.” Gorman v. Ameritrade Holding Corp., 293 F.3d 506, 509 (D.C.Cir.2002) (citing D.C.Code § 13-334(a) 2 ). The Due Process Clause permits such general jurisdiction over foreign corporations “only ... if the defendant’s business contacts with the forum district are ‘continuous and systematic.’ ” Id. at 509-10 (citing Helicopteros Nacionales de Colombia, S.A. v. Hall,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Poss v. Kern
District of Columbia, 2024
Dale v. Deutsche Telekom AG
N.D. Illinois, 2023
Smartmatic USA Corp. v. Powell
District of Columbia, 2023
Gligorov v. Nation of Brunei
District of Columbia, 2023
Lewis v. Mutond
District of Columbia, 2021
Elardi v. I.S. Makinen OY
S.D. Florida, 2019
Ofisi v. Bnp Paribas S.A.
District of Columbia, 2019
Leitner-Wise v. Clark
District of Columbia, 2018
Pao Tatneft v. Ukraine
District of Columbia, 2018
Tatneft v. Ukr.
301 F. Supp. 3d 175 (D.C. Circuit, 2018)
Davis v. Transportation Security Administration
196 F. Supp. 3d 106 (District of Columbia, 2016)
App Dynamic Ehf v. Vignisson
87 F. Supp. 3d 322 (District of Columbia, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
268 F. Supp. 2d 1, 2003 U.S. Dist. LEXIS 10549, 2003 WL 21464563, Counsel Stack Legal Research, https://law.counselstack.com/opinion/diamond-chemical-co-v-atofina-chemicals-inc-dcd-2003.